Prosiectau (178)
Cardiff University Schools involved in this Project
Genetic prediction of individuals at-risk for myopia development (01.04.2016 - 31.03.2019)
- Guggenheim, Jeremy
Optimum screening intervals for people with diabetes and non-sight threatening diabetic retinopathy (01.04.2016 - 31.10.2016)
- North, Rachel
Ostracod carapace as a novel transparent material (01.04.2016 - 30.09.2019)
- Meek, Keith
Novel drug therapy for mitochondrial optic neuropathy and other mitochondrial diseases (01.05.2016 - 31.12.2018)
- Rozanowska, Malgorzata
The biomechanics of the human lamina cribrosa and posterior sclera: Effects of age and glaucoma (30.09.2016 - 29.09.2018)
- Boote, Craig
A freedom to operate proposal to research targeted drug delivery to the cornea of the eye via thin-film slow release technology (01.10.2016 - 30.11.2016)
- Quantock, Andrew
Cellular and extracellular aspects of posterior eye microstructure and biomechanics (01.10.2016 - 30.04.2020)
- Markov, Petar
Changes in the visual cortex in glaucoma and their role in visual recovery: An fMRI-based study (01.10.2016 - 30.09.2021)
- Redmond, Tony
Gene-environment and gene-gene interactions in myopia (01.10.2016 - 30.09.2019)
- Guggenheim, Jeremy
Investigation of pain and discomfort associated with anti-VEGF injections (01.10.2016 - 30.06.2021)
- Wood, Ashley
Retinal predictors of visual performance in infantile nystagmus (03.10.2016 - 02.10.2019)
- Dunn, Matt J
Perceptual 'windows' in the presence of involuntary eye movements (01.11.2016 - 30.11.2022)
- Mcilreavy, Lee
Optic nerve microstructure: A significant indicator of disease severity (01.01.2017 - 30.03.2020)
- Albon, Julie
Targeted drug delivery to the cornea of the eye via thin-film slow release technology (01.05.2017 - 31.08.2018)
- Quantock, Andrew
Additional clinical testing for retinal predictors of visual performance in nystagmus (01.10.2017 - 30.09.2019)
- Dunn, Matt J
A tooth for an eye? The role of innate immune activation in glaucoma (01.10.2017 - 31.03.2021)
- Morgan, James
A novel treatment for blindness caused by autosomal dominant optic atrophy (17.10.2017 - 28.02.2019)
- Votruba, Marcela
TrkB receptor agonist antibody (AEB Ab# 85) and related TrkB agonist antibodies (01.11.2017 - 31.10.2018)
- Morgan, James
Diagnosing infantile nystagmus: A novel eye tracking approach (01.12.2017 - 30.11.2018)
- Mcilreavy, Lee
Evidencing the potential role of low vision service wales optometrists in the certification of vision impairment (15.12.2017 - 31.03.2022)
- Bartlett, Rebecca
The development of eye tissues via human induced pluripotent stem (IPS) cells (01.01.2018 - 31.12.2021)
- Quantock, Andrew
Japan Partnering Award: The generation of eye tissues from human induced pluripotent stem (iPS) cells (01.05.2018 - 01.09.2024)
- Quantock, Andrew
Improving the repeatability of MacuMap (01.07.2018 - 09.06.2019)
- Margrain, Tom
Crowding in glaucoma: A likely barrier to self-referral? (01.10.2018 - 30.09.2024)
- Redmond, Tony
Investigating the prevalence of uncorrected refractive error in the Homeless in the Wallich Homeless Centre, Wales (01.10.2018 - 31.01.2020)
- Morgan, James
The enhanced generation of the corneal epithelium from human induced pluripotent stem (hiPS) cells (01.10.2018 - 30.06.2022)
- Quantock, Andrew
The role of attention in peripheral vision (26.10.2018 - 25.04.2019)
- Dunn, Matt J
Improving VEP diagnostics in people with nystagmus (01.11.2018 - 30.04.2023)
- Dunn, Matt J
Improved eye tracking for MacuMap (01.02.2019 - 31.08.2019)
- Margrain, Tom
Targeted drug delivery to the cornea of the eye via medicated contact lenses and mucoadhesive thin films (01.02.2019 - 28.12.2022)
- Quantock, Andrew
The therapeutic potential of Genipin as a corneal cross-linking agent: Unlocking a new pathway for the treatment of corneal infection and disease (01.02.2019 - 31.01.2022)
- Meek, Keith
Near-infrared light therapy as a therapeutic regimen for inherited optic neuropathy (31.03.2019 - 31.07.2021)
- Votruba, Marcela
A mechanistic understanding of corneal pathobiology and the development and optimization of novel therapeutic strategies (01.09.2019 - 31.08.2024)
- Quantock, Andrew
Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma (01.10.2019 - 30.12.2022)
- Morgan, James
The genomic basis of human induced pluripotent stem (iPS) cell differentiation into eye-like tissues (01.11.2019 - 30.09.2024)
- Quantock, Andrew
Oculomotor control and visual perception during pursuit eye movements in the presence infantile nystagmus (01.01.2020 - 30.11.2021)
- Mcilreavy, Lee
Evaluation of errors in the delivery of care to patients with eye-related problems (02.01.2020 - 15.09.2023)
- Acton, Jennifer
Sustained release formulations for new drugs in the treatment of mitochondrial optic neuropathies (01.02.2020 - 11.02.2022)
- Votruba, Marcela
Evaluation of toric flat-pack contact lenses (10.03.2020 - 31.08.2021)
- Terry, Louise
Functional imaging of the outer retina using high fidelity imaging densitometry: exploring the relationship between visual pigment kinetics and AMD pathology (01.04.2020 - 30.06.2023)
- Wood, Ashley
Stem cell - derived exosomes for the treatment of Glaucoma (01.04.2020 - 30.09.2021)
- Mead, Benjamin
A multidisciplinary approach to early detection and staging disease in glaucoma (01.05.2020 - 31.01.2022)
- Albon, Julie
Oral glycoside supplement (triterpenoid saponins) for early and intermediate age related macular degeneration (AMD): An exploratory randomised controlled trial (01.08.2020 - 30.09.2024)
- Margrain, Tom
- Investigating a plausible mechanism underlying hallucinations in Charles
Bonnet Syndrome (01.09.2020 - 30.06.2023)- Dunn, Matt J
High fidelity imaging densitometry: exploring the relationship between visual pigment kinetics, choroidal vasculature and sub-retinal drusenoid deposits in age-related macular degeneration (01.10.2020 - 31.03.2024)
- Wood, Ashley
Hospital to Community: identifying the value of community optometrists monitoring and managing chronic eye disease in community practices (01.10.2020 - 28.02.2023)
- North, Rachel
Investigating the effects of brain-derived neurotrophic factor (BDNF) on retinal ganglion cell regeneration/recovery in a mouse model of glaucoma, using platelets as a novel delivery mechanism (01.10.2020 - 30.11.2021)
- Want, Andrew
Development of an eye tracking system for assessment in the home (01.12.2020 - 30.09.2022)
- Erichsen, Jonathan
Infantile nystagmus: Investigating the causes and establishing better measures of visual performance (01.01.2021 - 31.12.2024)
- Erichsen, Jonathan
Trauma Aid (01.04.2021 - 31.03.2023)
- Anderson, Philippa